E
Energenesis Biomedical Co Ltd
TWSE:6657
Energenesis Biomedical Co Ltd
TWSE:6657
Price:
45.65
TWD
-0.11%
Market Closed
Market Cap:
NT$4.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
TW |
|
C
|
CelcomDigi Bhd
KLSE:CDB
|
MY |
|
C
|
CSB Bank Ltd
BSE:542867
|
IN |
|
Hachi-Ban Co Ltd
TSE:9950
|
JP |
|
Vapotherm Inc
OTC:VAPO
|
US |
|
J
|
Jiangsu Akcome Science & Technology Co Ltd
SZSE:002610
|
CN |
|
Global Ship Lease Inc
NYSE:GSL
|
UK |
|
V
|
Vistra Corp
SWB:0V6
|
US |
|
China TransInfo Technology Co Ltd
SZSE:002373
|
CN |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
FINEOS Corporation Holdings PLC
ASX:FCL
|
IE |
|
L
|
Lianhua Supermarket Holdings Co Ltd
HKEX:980
|
CN |
|
D
|
Daiei Kankyo Co Ltd
TSE:9336
|
JP |
|
Educational Development Corp
NASDAQ:EDUC
|
US |
|
T
|
Tri-Mode System (M) Bhd
KLSE:TRIMODE
|
MY |
|
Federal Mogul Izmit Piston ve Pim Uretim Tesisleri AS
IST:FMIZP.E
|
TR |
|
SenseTime Group Inc
HKEX:20
|
CN |
|
KROMI Logistik AG
XETRA:K1R
|
DE |
|
B
|
Bowler Metcalf Ltd
JSE:BCF
|
ZA |
|
Mayfield Childcare Ltd
ASX:MFD
|
AU |
Relative Value
The Relative Value of one Energenesis Biomedical Co Ltd stock under the Base Case scenario is hidden TWD. Compared to the current market price of 45.65 TWD, Energenesis Biomedical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Energenesis Biomedical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Energenesis Biomedical Co Ltd Competitors
Energenesis Biomedical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
4B TWD | 542.9 | -16.6 | -13.6 | -12.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.2 | 24.6 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20.1 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.1 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 10.9 | 129.4 | 72.4 | 80.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
